Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Harrison

Showing results (161-170 of 199) with videos related to

Pageof 20
Sort By:
Journal of Neurobiology|December 18, 2001
A CUB-serine protease in the olfactory organ of the spiny lobster Panulirus argusM Z Levine, P J Harrison, W W Walthall, et al.
Neuroreport|April 19, 1995
Repeated ECS differentially affects rat brain 5-HT1A and 5-HT2A receptor expressionP W Burnet, A Mead, S L Eastwood, et al.
Neuroscience|June 29, 2004
Neuregulin-1 (NRG-1) mRNA and protein in the adult human brainA J Law, C Shannon Weickert, T M Hyde, et al.
Journal of Psychopharmacology (Oxford, England)|June 11, 2008
The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophreniaP J Harrison, L Lyon, L J Sartorius, et al.
European Journal of Pharmacology|February 28, 2001
Electroconvulsive shock increases tachykinin NK(1) receptors, but not the encoding mRNA, in rat cortexP W Burnet, R Miller, L J Lewis, et al.
Molecular Psychiatry|July 10, 2001
RNA editing of the 5-HT(2C) receptor is reduced in schizophreniaM S Sodhi, P W Burnet, A J Makoff, et al.
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration|December 1, 1996
Amyloid precursor protein mRNAs in Alzheimer's diseaseP J Harrison, W H Wighton-Benn, J M Heffernan, et al.
Molecular Psychiatry|January 25, 2012
Schizophrenia risk gene ZNF804A does not influence macroscopic brain structure: an MRI study in 892 volunteersH Cousijn, M Rijpkema, A Harteveld, et al.
Experimental Neurology|May 30, 1998
Temporal cortex synaptophysin mRNA is reduced in Alzheimer's disease and is negatively correlated with the severity of dementiaJ M Heffernan, S L Eastwood, Z Nagy, et al.
CNS & Neurological Disorders Drug Targets|April 10, 2012
The role of catechol-O-methyltransferase in reward processing and addictionE M Tunbridge, A Huber, S M Farrell, et al.
Pageof 20

Showing results (161-170 of 199) with videos related to

Sort By:
Pageof 20
Journal of Neurobiology|December 18, 2001
A CUB-serine protease in the olfactory organ of the spiny lobster Panulirus argusM Z Levine, P J Harrison, W W Walthall, et al.
Neuroreport|April 19, 1995
Repeated ECS differentially affects rat brain 5-HT1A and 5-HT2A receptor expressionP W Burnet, A Mead, S L Eastwood, et al.
Neuroscience|June 29, 2004
Neuregulin-1 (NRG-1) mRNA and protein in the adult human brainA J Law, C Shannon Weickert, T M Hyde, et al.
Journal of Psychopharmacology (Oxford, England)|June 11, 2008
The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophreniaP J Harrison, L Lyon, L J Sartorius, et al.
European Journal of Pharmacology|February 28, 2001
Electroconvulsive shock increases tachykinin NK(1) receptors, but not the encoding mRNA, in rat cortexP W Burnet, R Miller, L J Lewis, et al.
Molecular Psychiatry|July 10, 2001
RNA editing of the 5-HT(2C) receptor is reduced in schizophreniaM S Sodhi, P W Burnet, A J Makoff, et al.
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration|December 1, 1996
Amyloid precursor protein mRNAs in Alzheimer's diseaseP J Harrison, W H Wighton-Benn, J M Heffernan, et al.
Molecular Psychiatry|January 25, 2012
Schizophrenia risk gene ZNF804A does not influence macroscopic brain structure: an MRI study in 892 volunteersH Cousijn, M Rijpkema, A Harteveld, et al.
Experimental Neurology|May 30, 1998
Temporal cortex synaptophysin mRNA is reduced in Alzheimer's disease and is negatively correlated with the severity of dementiaJ M Heffernan, S L Eastwood, Z Nagy, et al.
CNS & Neurological Disorders Drug Targets|April 10, 2012
The role of catechol-O-methyltransferase in reward processing and addictionE M Tunbridge, A Huber, S M Farrell, et al.
Pageof 20